/ Print /

HEALTH MANAGEMENT

Survey report reveals how patients believe providers can drive better outcomesA report on a pair of surveys from West reveals interesting findings about patient engagement, prevention, wellness, and quality of care.
Guided therapy can improve antibiotic resistanceResearchers share surprising findings about PCT-guided therapy in antibiotic management in patients with respiratory infections.
Value-based payment update: Where we are and who is most successful
Value-based payment update: Where we are and who is most successfulWhile these types of programs have been in place for several years, it can be difficult to gauge who is using them and how, and whether they are achieving their intended goal.
Survey reveals how patients believe providers can drive better outcomesA study from West reveals interesting findings about patient engagement, prevention, wellness, and quality of care.
Five approaches to effective cancer care managementManaging the care for members with cancer is unlike managing care for other chronic diseases. Here’s five ways to better care for cancer patients.
Risk-contract engagement strategies should differ for independent, employed docsIf your organization is managing a risk-based contract, you are likely working hard to engage physicians. But are you modifying those efforts based on whether physicians are independent or employed? Here’s why you should.
Genetic testing: 3 things managed healthcare executives should knowA new survey on genetic testing has surprisingly results on consumer acceptance and impact for healthcare executives.
Four oncology treatment advances to watch
Four oncology treatment advances to watchExperts say a cancer care revolution is here. Here’s a closer look at some advancements in cancer treatments to watch.
Top 5 consumer health concernsA new survey from consumer health companies has revealing findings about American health and well-being.
Five questions for payers to ask when deciding coverage of genomic testsGenetics and genomics are starting to have an impact on cardiovascular care. Here’s what payers should consider when deciding whether to cover a gene expression test.